Top 5 Risers
|
Stock |
Rating |
Analysis |
DK |
BUY |
An increasingly attractive expected long term growth rate and a significantly higher projected valuation from just a few weeks ago make Delek a company to watch. |
ALJ |
BUY |
Alon has shown significant advances in achieving substantial earnings growth recently, and analysts also appear confident these higher earnings will continue to grow in the near future. |
UTHR |
BUY |
Projected value continues to rise for United Therapeutics while long term increases in earnings growth are also becoming more widely expected. |
NLY |
STRONGBUY |
The recent earnings history for Annaly shows significant improvement while projected valuation continues to rise. |
PDA |
BUY |
Perdigao is gaining higher expectations and its recent history of its earnings increases is significant. |